Pages that link to "Q44355272"
Jump to navigation
Jump to search
The following pages link to Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation (Q44355272):
Displaying 50 items.
- Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo (Q26798185) (← links)
- VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins (Q26827172) (← links)
- The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases (Q26851670) (← links)
- Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum (Q28566901) (← links)
- Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants (Q30991616) (← links)
- Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection (Q31172552) (← links)
- Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens. (Q33652057) (← links)
- Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention (Q33663970) (← links)
- Neurochemical phenotype of cytoglobin-expressing neurons in the rat hippocampus (Q33932413) (← links)
- VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice (Q34157261) (← links)
- Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions (Q34238010) (← links)
- Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. (Q34259060) (← links)
- Autoantibodies to alpha-synuclein in inherited Parkinson's disease. (Q35159805) (← links)
- Novel anti-inflammatory therapy for Parkinson's disease. (Q35198023) (← links)
- Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis (Q35295564) (← links)
- Single nucleotide polymorphisms in the 3'UTR of VPAC-1 cooperate in modulating gene expression and impact differently on the interaction with miR525-5p. (Q35414146) (← links)
- NF-κB in Aging and Disease (Q35806773) (← links)
- Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase (Q36156588) (← links)
- Neuropeptides: keeping the balance between pathogen immunity and immune tolerance (Q36158715) (← links)
- Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice (Q36373813) (← links)
- Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease (Q36616362) (← links)
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease (Q36741828) (← links)
- Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders (Q36830470) (← links)
- Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention (Q36919403) (← links)
- A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. (Q37015446) (← links)
- CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease (Q37015556) (← links)
- alpha-Synuclein: a therapeutic target for Parkinson's disease? (Q37070916) (← links)
- Oxidative and inflammatory pathways in Parkinson's disease (Q37117681) (← links)
- Treatment of Parkinson's disease with trophic factors (Q37131259) (← links)
- Neuronal influence behind the central nervous system regulation of the immune cells. (Q37136971) (← links)
- Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action (Q37171891) (← links)
- Innate and adaptive immunity for the pathobiology of Parkinson's disease (Q37401280) (← links)
- Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease (Q37765220) (← links)
- Transcriptional modulation by VIP: a rational target against inflammatory disease. (Q38019158) (← links)
- The role of inflammation in sporadic and familial Parkinson's disease (Q38105903) (← links)
- Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression (Q38354522) (← links)
- Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation (Q38495363) (← links)
- Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease (Q38622923) (← links)
- Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro (Q38946806) (← links)
- Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases (Q39116758) (← links)
- Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion (Q39771664) (← links)
- Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment? (Q41528091) (← links)
- Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. (Q42505593) (← links)
- Immunity and inflammation in neurodegenerative diseases (Q43104143) (← links)
- Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease. (Q45969431) (← links)
- Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats. (Q48793040) (← links)
- Focal, but not global, cerebral ischaemia causes loss of myenteric neurons and upregulation of vasoactive intestinal peptide in mouse ileum (Q57101692) (← links)
- Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development (Q61800365) (← links)
- Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels (Q81167475) (← links)
- Neuroinflammation and Parkinson's disease (Q82029459) (← links)